Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Breakthrough Bleeding
Interventions
DRUG

Doxycycline

40 mg orally at the start of cycle 3 (study day 57) for 28 days.

Trial Locations (1)

96826

Kapiolani Medical Center for Women and Children, Honolulu

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Charles Drew University of Medicine and Science

OTHER

collaborator

Meharry Medical College

OTHER

lead

University of Hawaii

OTHER

NCT01469585 - Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases | Biotech Hunter | Biotech Hunter